p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss

Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL‐stimulated NFATc1 activity

(2020) Yuhao Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates

(2020) Yasuo Endo et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice

(2020) Yunfei Zhan et al.   Frontiers in Pharmacology

Abaloparatide: A new pharmacological option for osteoporosis

(2019) Allyson Sleeman et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation

(2019) Sun-Ju Yi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Krüppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome

(2019) Mi Yang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Flufenamic acid inhibits osteoclast formation and bone resorption and act against estrogen-dependent bone loss in mice

(2019) Shutao Zhang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function

(2018) Wei Chen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway

(2018) Supatta Chawalitpong et al.   Scientific Reports

Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis

(2018) Chao Liang et al.   Nature Communications

Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9

(2018) Yukako Sakaguchi et al.   Scientific Reports

Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis

(2018) Huey-En Tzeng et al.   Scientific Reports

Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways

(2018) Qiang Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway

(2018) Thanintorn Yodthong et al.   MOLECULES

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

(2018) Ourania Nicolatou-Galitis et al.   SUPPORTIVE CARE IN CANCER

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

(2017) Loren M. Lasko et al.   NATURE

Clec11a/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton

(2016) Rui Yue et al.   eLife

Postmenopausal osteoporosis

(2016) Richard Eastell et al.   Nature Reviews Disease Primers

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

(2014) Nicole C Wright et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinician’s Guide to Prevention and Treatment of Osteoporosis

(2014) F. Cosman et al.   OSTEOPOROSIS INTERNATIONAL

Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis

(2013) Han Kyoung Choi et al.   CELL RESEARCH

Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition

(2013) Feng Wang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Bisphosphonates Induce Senescence in Normal Human Oral Keratinocytes

(2011) R.H. Kim et al.   JOURNAL OF DENTAL RESEARCH

Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer

(2010) Jan Bouchal et al.   PROSTATE

Osteonecrosis of the jaw — Who gets it, and why?

(2008) Ian R. Reid   BONE